Form 4: Masimo Corp Acquired by Danaher for $180 Per Share

Masimo Corporation has completed its merger with Danaher Corporation, resulting in the cancellation of outstanding common stock for $180 per share.

Summary

• Masimo Corporation completed a merger with Danaher Corporation on June 10, 2026.
• All outstanding shares of Masimo common stock were canceled and converted into the right to receive $180.00 per share in cash.
• Paul Hataishi, SVP and Chief Accounting Officer, disposed of 13,317 shares of common stock as part of the merger.
• Outstanding Restricted Stock Units (RSUs) held by the reporting person were assumed by Danaher Corporation and converted into Danaher RSU equivalents.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents the final administrative step of a previously announced merger rather than new operational or financial performance news.

Positives

• Shareholders received a cash consideration of $180.00 per share.
• Successful completion of the merger agreement dated February 16, 2026.

Negatives

• Masimo Corporation is no longer an independent publicly traded entity.
• The company has become a wholly owned subsidiary of Danaher Corporation.

Risks

• Integration risks associated with becoming a subsidiary of Danaher Corporation.
• Potential loss of independent corporate governance and operational autonomy.

Future Outlook

Masimo Corporation now operates as a wholly owned subsidiary of Danaher Corporation following the completion of the merger.

Management Comments

• The merger was executed pursuant to the Agreement and Plan of Merger dated February 16, 2026.

Industry Context

StockSavvy.ai notes that this acquisition represents a significant consolidation in the medical technology sector, aligning with broader trends of large-cap conglomerates acquiring specialized health-tech firms to bolster their portfolios.

Comparison to Industry Standards

• The $180 per share cash-out is consistent with standard acquisition premiums observed in recent medical device sector M&A activity.
• The conversion of unvested equity awards into parent company equity is a standard practice in large-scale corporate mergers.

Corporate Governance

Stakeholder Impact

• Shareholders receive cash consideration for their holdings.
• Employees transition to a subsidiary of Danaher Corporation.

Next Steps

• Delisting of Masimo Corporation common stock from public exchanges.
• Integration of Masimo operations into Danaher Corporation.

Key Dates

Keywords

Masimo, Danaher, Merger, Acquisition, MASI, SEC Form 4, Takeover